University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden

Not Applicable

Completed

Conditions: Tuberculosis
HIV/AIDS

Interventions: Behavioral: SPIRIT Intervention

First Posted Date: 2017-10-20

Last Posted Date: 2024-01-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 468

Registration Number: NCT03315962

Locations: 🇺🇬
Infectious Diseases Research Collaboration, Kampala, Uganda

Acupressure for Children in Treatment for a Childhood Cancer

Not Applicable

Completed

Conditions: Treatment-Related Cancer

Interventions: Other: Acupressure for Children in Treatment for a Childhood Cancer

First Posted Date: 2017-10-18

Last Posted Date: 2019-10-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 95

Registration Number: NCT03313193

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

T-Cell PET Imaging With [18F]F-AraG in Lung Cancer

Phase 2

Withdrawn

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: [18F]F-Ara-G
Drug: Pembrolizumab
Radiation: PET/CT scan

First Posted Date: 2017-10-17

Last Posted Date: 2019-10-21

Lead Sponsor: University of California, San Francisco

Registration Number: NCT03311672

Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.

Phase 4

Completed

Conditions: Pain, Acute

Interventions: Drug: Bupivacaine
Drug: Fentanyl

First Posted Date: 2017-10-11

Last Posted Date: 2020-05-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT03307174

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Recovery After Dialysis-Requiring Acute Kidney Injury

Not Applicable

Terminated

Conditions: Acute Kidney Injury

Interventions: Other: TIW dialysis strategy
Other: Conservative dialysis strategy

First Posted Date: 2017-10-10

Last Posted Date: 2019-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT03305549

Locations: 🇺🇸
UCSF Medical Center Moffitt-Long Hospital, San Francisco, California, United States

Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)

Phase 4

Completed

Conditions: Tuberculosis
HIV/AIDS
Alcohol Abuse

Interventions: Drug: Isoniazid 300 Mg ORAL TABLET
Drug: Pyridoxine 25 Mg Oral Tablet

First Posted Date: 2017-10-05

Last Posted Date: 2023-10-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 302

Registration Number: NCT03302299

Locations: 🇺🇬
Mbarara University of Science and Technology/Mbarara Regional Referral Hospital, Mbarara, Uganda

Diet Quality and LTL in NHANES

Completed

Conditions: Diet Habit
Telomere Length, Mean Leukocyte

First Posted Date: 2017-10-04

Last Posted Date: 2017-10-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4758

Registration Number: NCT03302104

Cognitive, Emotional, and Neural Responses to Acute Inflammation

Early Phase 1

Completed

Conditions: Healthy

Interventions: Biological: Typhoid Vi Polysaccharide Vaccine
Biological: Placebo

First Posted Date: 2017-09-27

Last Posted Date: 2019-06-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT03294564

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Phase 4

Completed

Conditions: Atopic Dermatitis
Eczema
Atopic Dermatitis Eczema
Atopic Dermatitis and Related Conditions

Interventions: Drug: Dupilumab

First Posted Date: 2017-09-26

Last Posted Date: 2024-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18

Registration Number: NCT03293030

Locations: 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

Completed

Conditions: Anticoagulants and Bleeding Disorders
Venous Thromboembolism

Interventions: Drug: Oral Anticoagulant

First Posted Date: 2017-09-25

Last Posted Date: 2022-11-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 39603

Registration Number: NCT03292666

Locations: 🇺🇸
Kaiser Permanente Southern California, Pasadena, California, United States
🇺🇸
Kaiser Permanente Northern California, Oakland, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy